Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia
Authors
Keywords
Pediatric acute myeloid leukemia, microRNA-375, Real-time quantitative PCR, Prognosis
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 383, Issue 1-2, Pages 59-65
Publisher
Springer Nature
Online
2013-07-17
DOI
10.1007/s11010-013-1754-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute myeloid leukemia: 2013 update on risk-stratification and management
- (2013) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- MicroRNA Dysregulation in Acute Myeloid Leukemia
- (2013) Carlo M. Croce JOURNAL OF CLINICAL ONCOLOGY
- Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia:miR-155Upregulation Independently Identifies High-Risk Patients
- (2013) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Decreased Expression of MicroRNA-375 in Nonsmall Cell Lung Cancer and its Clinical Significance
- (2013) Y Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma
- (2013) MY Siow et al. ORAL DISEASES
- Epidemiology of childhood acute myeloid leukemia
- (2013) Susan E. Puumala et al. PEDIATRIC BLOOD & CANCER
- Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia
- (2013) Feng Zhi et al. PLoS One
- The Role of Decitabine for the Treatment of Acute Myeloid Leukemia
- (2012) Alex Ganetsky ANNALS OF PHARMACOTHERAPY
- Prognostic value of miR-29a expression in pediatric acute myeloid leukemia
- (2012) Conglong Zhu et al. CLINICAL BIOCHEMISTRY
- Clinical Applications for microRNAs in Cancer
- (2012) S P Nana-Sinkam et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- MicroRNA as a novel drug target for cancer therapy
- (2012) Xiaoxia Liu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Prognostic impact of circulatingmiR-21andmiR-375in plasma of patients with esophageal squamous cell carcinoma
- (2012) Shuhei Komatsu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma
- (2012) Chongwang Chang et al. NEUROSCIENCE LETTERS
- Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas
- (2012) Setsuko Yabushita et al. PANCREAS
- miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells
- (2011) H. Zhao et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1
- (2011) Fenfen Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting miR-375 in gastric cancer
- (2011) Yanjun Xu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?
- (2011) Tereza Lopotová et al. LEUKEMIA RESEARCH
- Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
- (2011) Astrid A. Danen-van Oorschot et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation